Related references
Note: Only part of the references are listed.Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?
Monica Mangoni et al.
RADIOLOGIA MEDICA (2019)
First-Line Therapy for Metastatic Soft Tissue Sarcoma
Megan Meyer et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Diagnostic classification of soft tissue malignancies: A review and update from a surgical pathology perspective
Jeffrey M. Cloutier et al.
CURRENT PROBLEMS IN CANCER (2019)
Emerging Targeted and Immune-Based Therapies in Sarcoma
Seth M. Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression
Laura Brohee et al.
SCIENTIFIC REPORTS (2018)
Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
Marta Di Martile et al.
ONCOGENESIS (2018)
Propranolol inhibits proliferation and invasion of hemangioma-derived endothelial cells by suppressing the DLL4/Notch1/Akt pathway
Bin Sun et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma
Regina Alemany et al.
CLINICAL CANCER RESEARCH (2018)
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers
Rosa Maria Iacobazzi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
Antonella Borgatti et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma
Nicoletta Depalo et al.
NANO RESEARCH (2017)
PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways
Shengwei Liu et al.
ONCOTARGET (2017)
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy
Letizia Porcelli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials
A. Le Cesne et al.
ANNALS OF ONCOLOGY (2014)
Irradiation-induced angiosarcoma and anti-angiogenic therapy: A therapeutic hope?
Amalia Azzariti et al.
EXPERIMENTAL CELL RESEARCH (2014)
Sigma-2 Receptor Agonists as Possible Antitumor Agents in Resistant Tumors: Hints for Collateral Sensitivity
Mauro Niso et al.
CHEMMEDCHEM (2013)
Sarcoma Chemotherapy
Brian E. Walczak et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2013)
Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine
Xia Xie et al.
ONCOLOGY REPORTS (2013)
Targeting of Beta Adrenergic Receptors Results in Therapeutic Efficacy against Models of Hemangioendothelioma and Angiosarcoma
Jessica M. Stiles et al.
PLOS ONE (2013)
Systemic therapy for advanced soft tissue sarcomas Highlighting Novel Therapies and Treatment Approaches
Richard F. Riedel
CANCER (2012)
Molecular Pathways: Beta-Adrenergic Signaling in Cancer
Steven W. Cole et al.
CLINICAL CANCER RESEARCH (2012)
β-Adrenergic receptor expression in vascular tumors
Karen M. Chisholm et al.
MODERN PATHOLOGY (2012)
Involvement of Akt and mTOR in chemotherapeutic and hormonal-based drug resistance and response to radiation in breast cancer cells
Linda S. Steelman et al.
CELL CYCLE (2011)
Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma
Huiling Shen et al.
EXPERIMENTAL HEMATOLOGY (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
TGFβ1 antagonistic peptides inhibit TGFβ1-dependent angiogenesis
Simona Serrati et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Intracellular Trafficking of MDR Transporters and Relevance of SNPs
Letizia Porcelli et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines
Mariana G. Garcia et al.
LEUKEMIA RESEARCH (2009)
ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
Jiahao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans
I. Wessler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
Nicolas Penel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells
Balraj Singh et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells
Qing-Quan Li et al.
CANCER SCIENCE (2007)
Seven transmembrane receptors: something old, something new
R. J. Lefkowitz
ACTA PHYSIOLOGICA (2007)
Durable response of angiosarcoma of the face and scalp to docetaxel
M. Veliz et al.
CLINICAL ONCOLOGY (2007)
Characterization of β-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein
I Bachmakov et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)
The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β-blockers
D Palm et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Prognostic significance of activated AKT expression in soft-tissue sarcoma
Yasuhiko Tomita et al.
CLINICAL CANCER RESEARCH (2006)
Weekly low-dose docetaxel in the treatment of lung metastases from angiosarcoma of the head
M Yamada et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
被撤回的出版物: Regulation of cyclooxgenase-2 mRNA stability by taxanes - Evidence for involvement of p38, MAPKAPK-2, and HuR (Retracted article. See vol. 295, pg. 293, 2020)
K Subbaramaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Psychosocial stress augments tumor development through β-adrenergic activation in mice
H Hasegawa et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Share Paper
